XENE Xenon Pharmaceuticals | 8/7/2026 | Lower Price Target | $63.64 | $81.00 | Outperform | $0.00 00.00% ROI | |
EVMN Evommune | 8/7/2026 | Lower Price Target | $14.20 | $29.00 | Outperform | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 8/6/2026 | Lower Price Target | $9.42 | $13.00 | Outperform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 8/5/2026 | Boost Price Target | $28.32 | $37.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 8/5/2026 | Boost Price Target | $130.70 | $123.00 | Sector Perform | $0.00 00.00% ROI | |
CTNM Contineum Therapeutics | 7/31/2026 | Boost Price Target | $15.27 | $23.00 | Outperform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 7/31/2026 | Boost Price Target | $763.17 | $737.00 | Sector Perform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 7/31/2026 | Boost Price Target | $166.77 | $198.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 7/30/2026 | Lower Price Target | $205.31 | $240.00 | Outperform | $0.00 00.00% ROI | |
INCY Incyte | 7/29/2026 | Boost Price Target | $127.16 | $109.00 | Sector Perform | $0.00 00.00% ROI | |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
KYMR Kymera Therapeutics | 7/13/2026 | Downgrade | $119.35 | $115.00 | Sector Perform | $0.00 00.00% ROI | |
NMRA Neumora Therapeutics | 7/13/2026 | Lower Price Target | $1.62 | $5.00 | Outperform | $0.00 00.00% ROI | |
NRIX Nurix Therapeutics | 7/10/2026 | Boost Price Target | $23.97 | $33.00 | Outperform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 7/7/2026 | Boost Price Target | $529.59 | $570.00 | Outperform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 7/7/2026 | Boost Price Target | $85.44 | $85.00 | Sector Perform | $0.00 00.00% ROI | |
INCY Incyte | 7/7/2026 | Boost Price Target | $115.62 | $99.00 | Sector Perform | $0.00 00.00% ROI | |
BIIB Biogen | 7/7/2026 | Boost Price Target | $208.46 | $242.00 | Outperform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 7/7/2026 | Boost Price Target | $25.77 | $36.00 | Outperform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 7/7/2026 | Lower Price Target | $668.88 | $696.00 | Sector Perform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 7/7/2026 | Boost Price Target | $178.11 | $195.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 7/7/2026 | Lower Price Target | $134.71 | $120.00 | Sector Perform | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 7/7/2026 | Boost Price Target | $10.19 | $14.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 6/8/2026 | Reiterated Rating | $129.17 | | Sector Perform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 6/8/2026 | Boost Price Target | $86.92 | $97.00 | Sector Perform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 6/1/2026 | Reiterated Rating | $134.43 | $122.00 | Overweight | $0.00 00.00% ROI | |
GILD Gilead Sciences | 6/1/2026 | Upgrade | $131.10 | | Moderate Buy | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 5/29/2026 | Boost Price Target | $157.47 | $183.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 5/27/2026 | Boost Price Target | $193.08 | $227.00 | Outperform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 5/18/2026 | Lower Price Target | $623.32 | $707.00 | Sector Perform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 5/8/2026 | Lower Price Target | $130.55 | $122.00 | Sector Perform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 5/8/2026 | Boost Price Target | $79.08 | $82.00 | Sector Perform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 5/8/2026 | Boost Price Target | $55.89 | $82.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 5/6/2026 | Boost Price Target | $144.90 | $180.00 | Outperform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 5/5/2026 | Boost Price Target | $429.85 | $543.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 4/30/2026 | Boost Price Target | $191.32 | $222.00 | Outperform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 4/30/2026 | Lower Price Target | $707.09 | $762.00 | Sector Perform | $0.00 00.00% ROI | |
BIIB Biogen | 4/29/2026 | Boost Price Target | $191.58 | $222.00 | Outperform | $0.00 00.00% ROI | |
DMRA Damora Therapeutics, Inc. Common Stock | 4/24/2026 | Initiated Coverage | $25.42 | $40.00 | Outperform | $0.00 00.00% ROI | |
DMRA Damora Therapeutics, Inc. Common Stock | 4/23/2026 | Upgrade | $24.75 | | Moderate Buy | $0.00 00.00% ROI | |
EVMN Evommune | 4/10/2026 | Reiterated Rating | $27.56 | $48.00 | Outperform | $0.00 00.00% ROI | |
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself |
PHVS Pharvaris | 4/6/2026 | Lower Price Target | $28.56 | $51.00 | Outperform | $0.00 00.00% ROI | |
PHVS Pharvaris | 3/9/2026 | Initiated Coverage | $26.63 | $52.00 | Outperform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 3/2/2026 | Lower Price Target | $70.92 | $82.00 | Sector Perform | $0.00 00.00% ROI | |
AARD Aardvark Therapeutics | 3/2/2026 | Downgrade | $12.49 | $6.00 | Sector Perform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 3/2/2026 | Boost Price Target | $784.09 | $765.00 | Sector Perform | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 3/2/2026 | Boost Price Target | $17.69 | $13.00 | Sector Perform | $0.00 00.00% ROI | |
KYMR Kymera Therapeutics | 2/26/2026 | Reiterated Rating | $91.56 | $108.00 | Outperform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 2/26/2026 | Lower Price Target | $24.82 | $30.00 | Outperform | $0.00 00.00% ROI | |
LKFT Lakefront Biotherapeutics American Depositary Shares | 2/24/2026 | Boost Price Target | $34.36 | $33.00 | Sector Perform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 2/20/2026 | Lower Price Target | $69.90 | $82.00 | Sector Perform | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 2/20/2026 | Boost Price Target | $17.86 | $12.00 | Sector Perform | $0.00 00.00% ROI | |
PRTA Prothena | 2/20/2026 | Boost Price Target | $8.83 | $12.00 | Sector Perform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 2/13/2026 | Lower Price Target | $496.69 | $541.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 2/12/2026 | Lower Price Target | $126.01 | $177.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 2/11/2026 | Boost Price Target | $156.39 | $118.00 | Sector Perform | $0.00 00.00% ROI | |
INCY Incyte | 2/11/2026 | Lower Price Target | $98.59 | $92.00 | Sector Perform | $0.00 00.00% ROI | |
BIIB Biogen | 2/9/2026 | Boost Price Target | $201.18 | $233.00 | Outperform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 2/3/2026 | Lower Price Target | $26.13 | $31.00 | Outperform | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 1/30/2026 | Lower Price Target | $6.44 | $13.00 | Outperform | $0.00 00.00% ROI | |
NRIX Nurix Therapeutics | 1/29/2026 | Boost Price Target | $17.60 | $30.00 | Outperform | $0.00 00.00% ROI | |
GHRS GH Research | 1/23/2026 | Boost Price Target | $16.46 | $40.00 | Outperform | $0.00 00.00% ROI | |
DFTX Definium Therapeutics | 1/23/2026 | Boost Price Target | $17.29 | $36.00 | Outperform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 1/22/2026 | Downgrade | $81.91 | $83.00 | Sector Perform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 1/22/2026 | Upgrade | $461.14 | $546.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 1/20/2026 | Boost Price Target | $124.91 | $103.00 | Sector Perform | $0.00 00.00% ROI | |
BIIB Biogen | 1/13/2026 | Reiterated Rating | $178.30 | | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 1/8/2026 | Lower Price Target | $121.35 | $100.00 | Sector Perform | $0.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 1/8/2026 | Boost Price Target | $21.31 | $18.00 | Sector Perform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 1/6/2026 | Reiterated Rating | $78.59 | | Outperform | $0.00 00.00% ROI | |
KYMR Kymera Therapeutics | 12/16/2025 | Boost Price Target | $85.68 | $103.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 12/8/2025 | Boost Price Target | $159.46 | $180.00 | Outperform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 12/1/2025 | Downgrade | $85.99 | $91.00 | Sector Perform | $0.00 00.00% ROI | |
NMRA Neumora Therapeutics | 12/1/2025 | Upgrade | $2.26 | $7.00 | Outperform | $0.00 00.00% ROI | |
SION Sionna Therapeutics | 12/1/2025 | Reiterated Rating | $43.57 | $24.00 | Underperform | $0.00 00.00% ROI | |
CTNM Contineum Therapeutics | 11/21/2025 | Lower Price Target | $11.08 | $22.00 | Outperform | $0.00 00.00% ROI | |
CDTX Cidara Therapeutics | 11/17/2025 | Downgrade | $217.78 | | Sector Perform | $0.00 00.00% ROI | |
AARD Aardvark Therapeutics | 11/14/2025 | Lower Price Target | $10.86 | $18.00 | Outperform | $0.00 00.00% ROI | |
CRBP Corbus Pharmaceuticals | 11/13/2025 | Lower Price Target | $11.09 | $53.00 | Outperform | $0.00 00.00% ROI | |
PRTA Prothena | 11/7/2025 | Boost Price Target | $10.15 | $11.00 | Sector Perform | $0.00 00.00% ROI | |
DFTX Definium Therapeutics | 11/7/2025 | Lower Price Target | $11.26 | $20.00 | Outperform | $0.00 00.00% ROI | |
LKFT Lakefront Biotherapeutics American Depositary Shares | 11/7/2025 | Boost Price Target | $31.38 | $32.00 | Sector Perform | $0.00 00.00% ROI | |
CDTX Cidara Therapeutics | 11/7/2025 | Boost Price Target | $99.95 | $145.00 | Outperform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 11/6/2025 | Lower Price Target | $21.35 | $32.00 | Outperform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 11/5/2025 | Boost Price Target | $72.90 | $82.00 | Outperform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 11/4/2025 | Boost Price Target | $39.54 | $58.00 | Outperform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 11/4/2025 | Lower Price Target | $430.41 | $415.00 | Sector Perform | $0.00 00.00% ROI | |
KPTI Karyopharm Therapeutics | 11/4/2025 | Lower Price Target | $5.66 | $19.00 | Outperform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 11/3/2025 | Boost Price Target | $57.13 | $70.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 10/31/2025 | Lower Price Target | $149.61 | $210.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 10/31/2025 | Boost Price Target | $120.73 | $105.00 | Sector Perform | $0.00 00.00% ROI | |
Buy this stock today (Ad) Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7.
One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race. Get the name, ticker, and full Hotlist before markets open |
INCY Incyte | 10/29/2025 | Boost Price Target | $89.19 | $84.00 | Sector Perform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 10/29/2025 | Boost Price Target | $654.96 | $708.00 | Sector Perform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 10/29/2025 | Boost Price Target | $139.82 | $160.00 | Outperform | $0.00 00.00% ROI | |
LKFT Lakefront Biotherapeutics American Depositary Shares | 10/22/2025 | Boost Price Target | $32.33 | $28.00 | Sector Perform | $0.00 00.00% ROI | |
BIIB Biogen | 10/8/2025 | Lower Price Target | $152.21 | $217.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 10/8/2025 | Boost Price Target | $116.78 | $100.00 | Sector Perform | $0.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 10/8/2025 | Boost Price Target | $24.02 | $16.00 | Sector Perform | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 9/29/2025 | Reiterated Rating | $6.86 | $10.00 | Sector Perform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 9/25/2025 | Initiated Coverage | $38.42 | $60.00 | Outperform | $0.00 00.00% ROI | |
CDTX Cidara Therapeutics | 9/24/2025 | Set Price Target | $88.16 | $137.00 | Outperform | $0.00 00.00% ROI | |
INCY Incyte | 9/24/2025 | Boost Price Target | $84.54 | $81.00 | Sector Perform | $0.00 00.00% ROI | |
KYMR Kymera Therapeutics | 9/16/2025 | Initiated Coverage | $47.28 | $70.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 9/5/2025 | Boost Price Target | $143.76 | $149.00 | Outperform | $0.00 00.00% ROI | |
SION Sionna Therapeutics | 9/3/2025 | Initiated Coverage | $25.39 | $22.00 | Sector Perform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 9/2/2025 | Reiterated Rating | $39.12 | $55.00 | Outperform | $0.00 00.00% ROI | |
AARD Aardvark Therapeutics | 8/14/2025 | Lower Price Target | $11.44 | $19.00 | Outperform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 8/12/2025 | Lower Price Target | $36.96 | $55.00 | Outperform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 8/8/2025 | Reiterated Rating | $46.87 | $63.00 | Outperform | $0.00 00.00% ROI | |
ETNB 89BIO | 8/8/2025 | Lower Price Target | $8.92 | $11.00 | Sector Perform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 8/8/2025 | Boost Price Target | $119.21 | $98.00 | Sector Perform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 8/7/2025 | Boost Price Target | $23.84 | $40.00 | Outperform | $00.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 8/5/2025 | Lower Price Target | $389.93 | $405.00 | Sector Perform | $000.00 00.00% ROI | |
PRTA Prothena | 8/5/2025 | Lower Price Target | $7.28 | $10.00 | Sector Perform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 8/4/2025 | Boost Price Target | $569.71 | $695.00 | Sector Perform | $000.00 00.00% ROI | |
BIIB Biogen | 8/1/2025 | Boost Price Target | $126.28 | $219.00 | Outperform | $000.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 7/31/2025 | Lower Price Target | $129.41 | $144.00 | Outperform | $000.00 00.00% ROI | |
INCY Incyte | 7/30/2025 | Boost Price Target | $77.88 | $72.00 | Sector Perform | $000.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 7/17/2025 | Lower Price Target | $21.46 | $23.00 | Sector Perform | $00.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 6/30/2025 | Reiterated Rating | $9.23 | $13.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 6/25/2025 | Set Price Target | $126.16 | $213.00 | Outperform | $000.00 00.00% ROI | |
CDTX Cidara Therapeutics | 6/24/2025 | Upgrade | $49.86 | $75.00 | Moderate Buy | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 6/23/2025 | Boost Price Target | $22.12 | $38.00 | Outperform | $00.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 6/17/2025 | Set Price Target | $448.47 | $420.00 | Sector Perform | $000.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 5/27/2025 | Reiterated Rating | $599.20 | $662.00 | Sector Perform | $000.00 00.00% ROI | |
CTNM Contineum Therapeutics | 5/15/2025 | Reiterated Rating | $3.72 | $31.00 | Outperform | $00.00 00.00% ROI | |
KPTI Karyopharm Therapeutics | 5/13/2025 | Lower Price Target | $5.40 | $33.00 | Outperform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 5/13/2025 | Lower Price Target | $29.93 | $55.00 | Outperform | $00.00 00.00% ROI | |
CRBP Corbus Pharmaceuticals | 5/7/2025 | Lower Price Target | $6.34 | $58.00 | Outperform | $00.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 5/6/2025 | Boost Price Target | $434.64 | $423.00 | Sector Perform | $000.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 5/6/2025 | Reiterated Rating | $10.40 | $13.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 5/2/2025 | Lower Price Target | $122.38 | $205.00 | Outperform | $000.00 00.00% ROI | |
INCY Incyte | 4/30/2025 | Boost Price Target | $61.11 | $67.00 | Sector Perform | $00.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 4/30/2025 | Lower Price Target | $586.51 | $943.00 | Outperform | $000.00 00.00% ROI | |
LEGN Legend Biotech | 4/22/2025 | Reiterated Rating | $33.48 | $84.00 | Outperform | $00.00 00.00% ROI | |
BIIB Biogen | 4/22/2025 | Boost Price Target | $117.63 | $225.00 | Outperform | $000.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 4/14/2025 | Upgrade | $90.87 | $137.00 | Outperform | $000.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 4/11/2025 | Reiterated Rating | $6.55 | $11.00 | Outperform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 4/1/2025 | Boost Price Target | $487.06 | $420.00 | Sector Perform | $000.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 3/31/2025 | Downgrade | $70.41 | $87.00 | Sector Perform | $00.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 3/18/2025 | Initiated Coverage | $38.67 | $67.00 | Outperform | $00.00 00.00% ROI | |
Your $29.97 book is free today (Ad) Why Some Traders Skip Stocks Entirely
You don't need a big account to trade options.
In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up.
This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account. Normally $29.97. Today it's free. Grab your copy now. |
AARD Aardvark Therapeutics | 3/10/2025 | Initiated Coverage | $10.13 | $21.00 | Outperform | $0.00 00.00% ROI | |
GHRS GH Research | 3/7/2025 | Initiated Coverage | $10.55 | $31.00 | Outperform | $00.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 2/27/2025 | Lower Price Target | $107.24 | $161.00 | Outperform | $00.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 2/25/2025 | Reiterated Rating | $8.11 | $11.00 | Outperform | $0.00 00.00% ROI | |
PRTA Prothena | 2/21/2025 | Lower Price Target | $15.61 | $20.00 | Sector Perform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 2/20/2025 | Boost Price Target | $475.68 | $408.00 | Sector Perform | $000.00 00.00% ROI | |
KPTI Karyopharm Therapeutics | 2/20/2025 | Reiterated Rating | $9.41 | $45.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 2/13/2025 | Lower Price Target | $135.56 | $225.00 | Outperform | $000.00 00.00% ROI | |
GILD Gilead Sciences | 2/12/2025 | Boost Price Target | $103.52 | $90.00 | Sector Perform | $000.00 00.00% ROI | |
INCY Incyte | 2/11/2025 | Lower Price Target | $68.30 | $68.00 | Sector Perform | $000.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 2/11/2025 | Boost Price Target | $459.15 | $407.00 | Sector Perform | $000.00 00.00% ROI | |
PLRX Pliant Therapeutics | 2/10/2025 | Downgrade | $7.79 | $4.00 | Sector Perform | $0.00 00.00% ROI | |
KPTI Karyopharm Therapeutics | 2/10/2025 | Reiterated Rating | $9.77 | $45.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 2/7/2025 | Lower Price Target | $122.00 | $148.00 | Sector Perform | $000.00 00.00% ROI | |
GILD Gilead Sciences | 2/3/2025 | Reiterated Rating | $99.12 | $84.00 | Sector Perform | $000.00 00.00% ROI | |
AXSM Axsome Therapeutics | 1/29/2025 | Reiterated Rating | $104.53 | $139.00 | Outperform | $000.00 00.00% ROI | |